Establishment Labs Holdings Inc

Establishment Labs Holdings Inc(ESTA)股票分析

$63.520

+1.264 (+1.99%)收盤時

Loading chart…
最高
65.610
開盤
62.070
成交量加權均價
63.70
成交量
762.56K
市值
1.21B
最低
61.980
成交金額
48.58M
企業價值/稅息折舊攤銷前利潤(TTM)
-185.20

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

AI 分析 of Establishment Labs Holdings Inc (ESTA)

持有

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

分析師評級(3)

上檔空間 +30.48%
買進
3 買進
0 持有
0 賣出
目前: 63.52
最低
75.00
平均
82.88
最高
90.00

Citi

2026-08-13

目標價

$92

買進

Canaccord

2026-08-07

目標價

$105

買進

Mizuho

2026-07-15

目標價

$105

優於大盤

Citi

2026-07-08

目標價

$92

中性

BTIG

2026-05-07

目標價

$90

買進

估值指標

Establishment Labs Holdings Inc(ESTA)目前預期本益比為 204.08,5 年平均預期本益比為 -19.64。

預期本益比

嚴重高估
5 年均值 P/E
-19.64
目前P/E
204.08
高估
24.17
低估
-63.44

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-83.72
目前EV/EBITDA
-185.20
高估
41.95
低估
-209.40

預期股價營收比

合理
5 年均值 P/S
6.99
目前P/S
5.37
高估
8.79
低估
5.20

Alphio AI 對 ESTA 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ESTA

$56.20

情境價格

基

基準

基準 · 50%ESTA

$47.64

情境價格

悲

悲觀

悲觀 · 25%ESTA

$46.67

情境價格

持有 ESTA 的大戶

R

Rice Hall James & Associates, LLC

+ 持有ESTA

+1.11%

3個月報酬率

S

Summit Partners Public Asset Management, LLC

+ 持有ESTA

-3.60%

3個月報酬率

R

RTW Investments, LP

+ 持有ESTA

-7.17%

3個月報酬率

B

Boothbay Fund Management, LLC

+ 持有ESTA

-8.82%

3個月報酬率

A

ADAR1 Capital Management, LLC

+ 持有ESTA

-11.93%

3個月報酬率

事件時間軸

2026-09-21 (ET)

08:31:00

Establishment Labs Presents New Data on Breast Tissue Preservation

2026-06-29 (ET)

08:30:00

Establishment Labs Appoints Taylor Harris to Board of Directors

2026-05-06 (ET)

08:10:00

Company Expects Minimally Invasive Business to Exceed $35M in 2026

08:10:00

Company Reports Q1 Revenue of $59.9M, Exceeding Expectations

2026-04-30 (ET)

09:00:00

Establishment Labs Secures $300M Loan Facility

資訊

ESTA 常見問題 —— 由 Alphio AI 解答

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易